National Health (NHI) analyst forecast and price target
Analyst forecast
Consensus of 8 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Truist Securities | Maintained | Buy | $80.00 from $81.00 | Sep 2, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $78.00 from $79.00 | Sep 1, 2026 |
| Deutsche Bank | Maintained | Hold | $80.00 from $85.00 | Jun 25, 2026 |
| BMO Capital | Maintained | Outperform | $80.00 from $90.00 | Jun 15, 2026 |
| Truist Securities | Maintained | Buy | $81.00 from $89.00 | Jun 12, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $79.00 from $84.00 | Jun 1, 2026 |
| Truist Securities | Maintained | Buy | $89.00 from $92.00 | Apr 22, 2026 |
| Cantor Fitzgerald | Maintained | Overweight | $94.00 | Apr 22, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $84.00 from $86.00 | Apr 22, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $86.00 from $85.00 | Mar 27, 2026 |
| Truist Securities | Maintained | Buy | $92.00 from $85.00 | Mar 12, 2026 |
| Truist Securities | Maintained | Buy | $83.00 from $81.00 | Dec 16, 2025 |
| Keybanc | Maintained | Overweight | $88.00 from $80.00 | Dec 4, 2025 |
| Wells Fargo | Maintained | Equal-Weight | $85.00 from $80.00 | Nov 25, 2025 |
| Cantor Fitzgerald | Initiated Coverage | Overweight | $90.00 | Oct 1, 2025 |
| Wells Fargo | Maintained | Equal-Weight | $80.00 from $76.00 | Aug 27, 2025 |
| Truist Securities | Maintained | Buy | $81.00 from $77.00 | Aug 15, 2025 |
| Keybanc | Upgraded | Sector Weight → Overweight | $80.00 | Jul 10, 2025 |
| Truist Securities | Maintained | Hold | $77.00 from $76.00 | Jun 9, 2025 |
| Truist Securities | Maintained | Hold | $76.00 from $70.00 | Mar 19, 2025 |
Frequently asked questions
Is NHI a buy, sell, or hold?
Analysts covering National Health currently average a Buy rating: 5 buy, 3 hold and 0 sell, from 8 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on NHI?
On Sep 2, 2026, Truist Securities maintained National Health at Buy with a price target of $80.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.